VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Valneva SE

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 17, 2026

$5.51−0.10 (-1.78%)

Close on Oct 19, 2026

Valneva SE revenue by segment

Valneva does not break out revenue by segment, region or product in the tagged data of its filings for this period type.